Summary
This data collection consists of
The full title can be “Radiomic Biomarkers in Oropharyngeal Carcinoma”.
oropharynx squamous cell carcinoma
This will be sufficient for the 2 manuscripts that use the data to be shared on TCIA.
Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in Oropharyngeal Carcinoma
One is PMID 26264429, and the other is not yet on Pubmed but has recently gone In Press:
https://www.sciencedirect.com/science/article/pii/S0360301618301299
Purpose: Distant metastasis (DM) is the main cause of death for patients with human papillomavirus (HPV)-related oropharyngeal cancers (OPC); yet there are few reliable predictors of DM in this disease. The role of quantitative imaging (i.e. radiomic) analysis was examined to determine whether there are primary tumor features discernible on imaging studies that associate with a higher risk of developing DM.
Methods: Radiotherapy planning CT scans were retrieved for all non-metastatic p16-positive OPC patients treated with radiotherapy or chemoradiotherapy at a single institution between 2005 and 2010. Radiomic biomarkers were derived from each gross tumor volume (GTV). Biomarkers included four representative radiomic features from tumor first order statistics, shape, texture, and wavelet groups as well as a combined four-feature signature. Univariable Cox proportional hazards models for DM risk were identified. Discriminative performance of prognostic univariable and multivariable models was compared using the concordance index (C-index). Subgroup analyses were performed.
Results: There were 300 HPV-related OPC patients who were eligible for the analysis. A total of 36 DM events occurred within a median follow-up of five years. On univariable analysis, top results included the four representative radiomic features (p<0.001), the radiomic signature (p<0.001), tumor stage (p<0.001), tumor diameter (p<0.001), and tumor volume (p<0.001). C-indices of the radiomic features (0.670-0.686), radiomic signature (0.670), stage (0.633), and tumor size metrics (0.653-0.674) demonstrated moderate discrimination of DM risk. Combined clinical-radiomic models yielded significantly improved performance (0.701-0.714; p<0.05). In subgroup analyses, the radiomic biomarkers consistently stratified patients for DM risk, particularly for those cohorts with greater risks (0.663-0.796), such as patients with stage III disease.
Conclusions: Radiomic biomarkers appear to classify DM risk for patients with non-metastatic HPV-related OPC. Radiomic biomarkers could be used either alone or with other clinical characteristics in assignment of DM risk in future HPV-related OPC clinical trials.
Oropharynx cancer is increasing in frequency in North America. More refined risk stratification and treatment personalization strategies are needed to improve cure rates and limit toxicities. Radomic features have shown promise for prognostication in oropharynx cancer based on datasets including hundreds of patients. Clinical outcomes data for oropharynx cancer patients treated at Princess Margaret Cancer Centre is of the highest quality, collected prospectively at the point of care. This data has resulted in the recent AJCC/UICC 8th edition staging system for oropharynx cancer (first published by O'Sullivan et al. in Lancet Oncology, 2016 [PMID 26936027]). By making publicly available the published data from our institution, which has now been published twice (see next question), we will empower researchers to perform meta-analysis and validation exercises of prognostic radiomic models. Ultimately this will lead to more robust models and bring us closer to clinical implementation and impact for our patients.
For scientific inquiries about this dataset, please contact: Dr. Scott Bratman Scott.Bratman@rmp.uhn.ca
Data Access
Choosing the Download option will provide you with a file to launch the TCIA Download Manager to download the entire collection. If you want to browse or filter the data to select only specific scans/studies please use the Search option.
Data Type | Download all or Query/Filter |
---|---|
Images (DICOM, XX GB) | |
Clinical (e.g. patient demographics, outcomes) | |
Detailed clinical, genomic, and expression array data |
Click the Versions tab for more info about data releases.
Detailed Description
Collection Statistics |
|
---|---|
Modalities | |
Number of Patients | |
Number of Studies | |
Number of Series | |
Number of Images | |
Image Size (GB) |
Supporting Documentation
In addition to the DICOM images in TCIA,
Citations & Data Usage Policy
This collection is freely available to browse, download, and use for commercial, scientific and educational purposes as outlined in the Creative Commons Attribution 3.0 Unported License. See TCIA's Data Usage Policies and Restrictions for additional details. Questions may be directed to help@cancerimagingarchive.net.
Please be sure to include the following citations in your work if you use this data set:
Data Citation
Authors (2018). Data from Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in Oropharyngeal Carcinoma. The Cancer Imaging Archive. http://dx.doi.org link coming soon
Publication Citation
Coming soon
TCIA Citation
Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. (paper)
Other Publications Using This Data
TCIA maintains a list of publications which leverage our data. At this time we are not aware of any publications based on this data. If you have a publication you'd like to add please contact the TCIA Helpdesk.
Version 1 (Current): Updated 2018/xx/xx
Data Type | Download all or Query/Filter |
---|---|
Images (DICOM, XXX.X GB) | |
Summary clinical data | |
Detailed clinical, genomic, and expression array data |